GlassScriptPhysician profile
Amy L Schaag
NPI 1356867816
$2,000.77
in general payments reported to CMS, 2019-2025
19 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $111 · 2021: $502 · 2022: $253 · 2023: $428 · 2024: $248 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.73 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $546.15 | 2022-2025 | Infuse, Xiidra, Miebo |
| Alcon Vision LLC | $287.67 | 2019-2025 | Total30, Precision 1, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $160.13 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $140.03 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $128.89 | 2020-2023 | |
| Kala Pharmaceuticals, INC. | $123.73 | 2021 | |
| Horizon Therapeutics Plc | $122.61 | 2021 | |
| Allergan, INC. | $111.71 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.99 | 2019-2021 | |
| Thea Pharma INC. | $62.60 | 2023-2024 | Iyuzeh |
| Carl Zeiss Meditec, INC. | $55.56 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $32.42 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $31.20 | 2021-2023 | Cequa |
| Harrow Eye, LLC | $22.11 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $18.45 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.77 | 2022 | |
| Dompe US, INC. | $17.22 | 2021 | |
| Coopervision INC. | $17.05 | 2022 | |
| Abb Con-Cise Optical Group LLC | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Schaag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.